tradingkey.logo
tradingkey.logo
Search

Acadia Healthcare Company Inc

ACHC
Add to Watchlist
24.960USD
+0.420+1.71%
Close 06/24, 16:00ETQuotes delayed by 15 min
2.30BMarket Cap
LossP/E TTM

Earnings Forecast

Currency: USD Updated: 2026-06-24
Previous score
7.14
Change
0
The current earnings forecast score of Acadia Healthcare Company Inc is 7.14, ranking 45 out of 76 in the Healthcare Providers & Services industry. The average price target is 22.50, with a high of 34.00 and a low of 13.00.

Analyst Rating

Based on 14 analysts
Buy
Current Rating
28.857
Target Price
+16.03%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

68
Total
8
Median
9
Average
Company name
Ratings
Analysts
Acadia Healthcare Company Inc
ACHC
14
CVS Health Corp
CVS
29
Teladoc Health Inc
TDOC
27
HCA Healthcare Inc
HCA
26
Tenet Healthcare Corp
THC
23
Natera Inc
NTRA
23
1
2
3
...
14

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Forecast
Actual

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

FAQs

What is Acadia Healthcare Company Inc's expected revenue for the next quarter?

Acadia Healthcare Company Inc's expected revenue is 844.15M.

What is Acadia Healthcare Company Inc's price target?

Analysts forecast that Acadia Healthcare Company Inc's price target is USD 22.50, with the highest forecast at USD 34.00 and the lowest forecast at USD 13.00.

How have Acadia Healthcare Company IncACHC's recent earnings per share performed?

The market expectation was USD 0.05, while Acadia Healthcare Company IncACHC's earnings per share (EPS) for the previous quarter was USD -13.02. EPS for the next quarter is expected at USD 0.38.

What is the analyst rating for Acadia Healthcare Company Inc?

Based on the ratings of Acadia Healthcare Company Inc's stock from 14 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
KeyAI